Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine

Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill?

Gepirone was recently launched and FDA-approved for MDD. It belongs to azapirones group of psychotropics that is in popular use in Japan and China. Here, author wraps up current knowledge on gepirone contrasted with the older and cheaper anxiolytic buspirone.

Drug-Induced Bruxism: a Comprehensive Literature Review

Bruxism is a parafunctional teeth grinding activity that is attributed to be of multifactorial origin. The aim of this article is to provide a brief overview on drug-induced bruxism, commonly associated drugs, and its possible pathogenic mechanisms. Around 43 relevant publications were selected after a comprehensive search in PubMed, Cochrane library, Science Direct, and Google Scholar with appropriate keywords to collect data and compile this review. Disturbances in the neurotransmitters and their receptors in the central nervous system may play a significant role, particularly in sleep bruxism. Drugs that interfere normal secretion and function of neurotransmitters are documented to be capable of inducing bruxism. Such psychotropic drugs are being used in clinical practice chiefly for the management of mood disorders, anxiety, and depression. Although bruxism is a well-recognized side effect of certain medications, the extent of awareness about the same is still inadequate among dental professionals.

Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism

Bruxism is a repetitive jaw‐muscle activity characterised by clenching or grinding of the teeth and/or by bracing or thrusting of the mandible. It can occur during sleep, indicated as sleep bruxism, or during wakefulness, indicated as awake bruxism. Exogenous risk indicators of sleep bruxism and/or awake bruxism are, among others, medications and addictive substances, whereas also several medications seem to have the potential to attenuate sleep bruxism and/or awake bruxism. The objective of this study was to present a narrative literature on medications and addictive substances potentially inducing or aggravating sleep bruxism and/or awake bruxism and on medications potentially attenuating sleep bruxism and/or awake bruxism. Literature reviews reporting evidence or indications for sleep bruxism and/or awake bruxism as an adverse effect of several (classes of) medications as well as some addictive substances and literature reviews on medications potentially attenuating sleep bruxism and/or awake bruxism were used as starting point and guidelines to describe the topics mentioned. Additionally, two literature searches were established on PubMed. Three types of bruxism were distinguished: sleep bruxism, awake bruxism and non‐specified bruxism. Generally, there are insufficient evidence‐based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism. There are insufficient evidence‐based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism.